GLP-1s Mechanism in Appetite & Weight Regulation Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the -cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus
Important note: My personal experimentation should not be taken as medical advice
gim thiu np nhn
The LR3 modification allows more unbound peptide to remain biologically active
Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity, Frontiers in Nutrition (2024) Obesity and comorbid conditions, StatPearls (2024) FDA approves generic liraglutide to address GLP-1 drug shortage, Journal of the American Medical Association (2024) Annual report, Novo Nordisk (2024) Liraglutide for weight management: a critical review of the evidence, Obesity Science & Practice (2016) Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study, International Journal of Obesity (2013) Real-world clinical effectiveness of liraglutide for weight management in Trkiye: insights from the LIRA-TR study, Journal of Clinical Medicine (2024) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Efficacy of semaglutide in treating obesity: a systematic review of randomized controlled trials (RCTs), Cureus (2022) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial, Nature Medicine (2024) Oral semaglutide versus empagliflozin in patients with Type 2 diabetes uncontrolled on metformin: the PIONEER 2 trial, Diabetes Care (2019) Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial, Journal of the American Medical Association (2022) One-year weight reduction with semaglutide or liraglutide in clinical practice, JAMA Network Open (2024) Liraglutide versus semaglutide for weight reduction-a cost needed to treat analysis, Obesity (2023) Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis, Frontiers in Pharmacology (2025) Comparing the efficacy of liraglutide and semaglutide on weight loss: Experience from the Middle East Gulf region and literature review, Hospital Pharmacy (2025) Saxenda label, DailyMed (2025) Ozempic label, DailyMed (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
After two weeks, I noticed my acne spots fading and my skin texture feeling smoother
